Download omotola olasupo - College of Pharmacy

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
OMOTOLA OLASUPO
Office: 1225 Center Drive, HPNP 2314, Gainesville, FL 32611, Mailing Address: P.O. Box 100496, Gainesville, FL. 32610
Fax: +1-352.846.5097, E-mail: [email protected], [email protected].
EDUCATION
Doctor of Philosophy in Pharmaceutical Outcomes & Policy
2015 - Present
University of Florida, Gainesville, FL.
Interests: Budget-impact modelling, Comparative Effectiveness studies, Drug Regulatory and Patient safety studies
for Biotechnology and vaccines, Health Policy and Behavioral science.
Bachelor of Pharmacy
University of Ibadan, Nigeria.
2000- 2006
LICENSES & CERTIFICATIONS
Proficiency Certificate in Management, Nigerian Institute of management, NIM
Pharmacists’ License, Pharmacists’ Council of Nigeria ( PCN)
2008
2006-Present
PROFESSIONAL EXPERIENCE
Field Force Manager, Oncology.
January 2014 – January 2015
Roche Products, Nigeria
(A multinational pharmaceutical company with specialty in Biotechnology and in-vitro diagnostics)







Planned and managed Key Accounts in the public and private health sector involved in the management
of Breast cancer, colorectal cancer, Non-Hodgkin’s Lymphoma and Rheumatoid Arthritis.
Built and maintained professional relationships with a nationwide base of clinicians, payers and other
stakeholders to ensure access to innovative healthcare in Oncology, Haematology & Rheumatology.
Carried out Market research and analysis to develop product promotion strategies for products at
different stages of the product lifecycle.
Led and supervised the performance of the sales team comprising Medical representatives & Distributor
representatives within the organizational framework for career coaching & in-field effectiveness.
Ensured all resources (Field force time, budgets and work tools) were efficiently used in achieving
optimum return-on-investments in assigned projects.
Communicated from top management to the sales team in ensuring successful implementation of action
plans and adherence to internal operation guidelines.
Achieved 8% growth in Franchise sales over previous year.
Consultant Medical Representative,
Roche Products Nigeria.






December 2010 – January 2014
Medical Detailing on Trastuzumab in HER2+ Breast Cancer, Rituximab in CD20+ Non-Hodgkin’s
Lymphoma and Rheumatoid Arthritis, Bevacizumab in all indications, Capecitabine in all indications and
Filgrastim in the treatment of Neutropenia.
Promoted best practices and adoption of standard treatment protocols in the relevant fields of Oncology,
Haematology and Rheumatology by the distribution of guidelines and encouraging multi-disciplinary
approach to patient care.
Planned and executed capability building and educational programmes for clinicians and other healthcare
professionals e.g. Nigerian Oncology Pharmacy Group, Lymphoma Forum (LymphF) & product
presentations.
Facilitated routine Immunohistochemistry tests required for the treatment of HER2 positive breast cancer
and CD20 positive Non-Hodgkin’s Lymphoma.
Developed professional relationships and Liaisons with stake-holders in healthcare (prescribers,
pharmacists, payers groups and government) and achieved better access to Roche products.
Achieved 100% of monthly and yearly sales targets representing a 50% increase in product sales within
the first year and sustained over the next 2 years.
Medical Representative.
August 2009 – December 2010.
Eli Lilly & Company - CHI Pharmaceuticals Limited, Lagos, Nigeria.
(A multinational pharmaceutical company with specialty in Diabetes care and Oncology)





Detailed on Human Insulin and analogues, Gemcitabine, Tadalafil and Olanzapine in the management of
Diabetes mellitus, Cancers, Erectile dysfunction and Psychiatry.
Organised scientific conferences and seminars for specialists in the related fields of Endocrinology,
Internal Medicine, Oncology and Neuro-psychiatry.
Built professional relationships and liaisons with medical personnel in these fields aimed at achieving
best clinical outcomes as well as achieving sales, with a resultant significant increase in sales in the
region.
Initiated the adoption of the Insulin analogue, Humalog® in the territory following product launch.
Achieved monthly sales target and grew the business significantly over previous years.
Retail and Community Pharmacist.
November 2008 – July 2009
HealthPlus Pharmacy, Lagos, Nigeria
 Provided drug advisory services on medication use, body fitness, weight management, smoking
cessation, public health and travel concerns.
 Supervised staff (approx. 3-4 Pharmacy assistants) and activities e.g. merchandizing & invoicing.
National Youth Service - Public Health
October 2007 – September 2008
Health Department, Ikeduru Local Government, Imo State, Nigeria.
 Implemented Government Health policies eg. Roll-Back-Malaria and Immunizations.
 Achieved better inventory control with increased patient base and monthly turnover.
 Independent monitor, National programme on Immunization (NPI), World Health Organization (WHO):
monitored the vaccination exercise for children 1-60months old.
Internship (Clinicals)
July 2006-June 2007
University College Hospital, Ibadan, Nigeria
 Provided total pharmaceutical care, Drug dispensing, compounding and patient counselling on drug use.
 Monitored controlled drugs and drugs of addiction.
 Clinical Presentations.
RESEARCH
Causes and Consequences of Anti-biotic resistance. Olasupo O, Alshaeri H, Jambi A, Alsharaimy F,
Bojan B, Alnafesall A. 2015 - Ongoing Review.
An Assessment of the Therapeutic Biologic Products Licensed by the FDA and EMA (1995-2014).
Grazdanova A, Olasupo O, Seoane E. 2015. (ISPOR Research Poster Presentation, 2015)
Assessment Audit of Health Facilities for Cancer prevention, Diagnosis and Management in Lagos
state, Lagos State Ministry of Health. (Data Collection), 2014
Epidemiology of breast cancer and HER-2 over-expression in Nigeria, 2011 (Non-interventional prospective
study) and Case reports of treatment outcomes with Rituximab in the management of Non-Hodgkin’s
Lymphoma, 2011-2014 - Support Role to the Medical team.
The Use of Artemisinin-based Combination Therapy (Dihydroartemisinin/Amodiaquine) in the
management of drug-resistant falciparum malaria. Bachelor of Pharmacy Final year Project,
Department of Pharmacology and Therapeutics, College of Medicine, University College Hospital, Ibadan.
(Literature review & Clinical Observation), 2006. Supervisor: Prof. G.O. Gbotosho
PROFESSIONAL TRAINING
Systematic Reviews & Meta-Analysis: Applications, ISPOR Distant Learning Centre, 2015
Modeling Health Care costs I: Characteristics of Health Care Costs, 2015
Introduction to outcomes research., 2014
Project Management, Marina HRSolutions - Roche Products, May 2014
Key Accounts Management and Planning, Innovara Inc. Massachusetts - Roche Products, July 2013
Advanced Selling Skills. Roche CEMAI- Training Centre, Nairobi, Kenya, Sept. 2011
Oncology Product Training and Supportive Care, Roche Training Centre, Nairobi, Kenya, Apr 2011
Management of Metastatic Breast Cancer: First-line Gemcitabine Therapy, Eli Lilly & Co., Mar 2010
Soluble Insulin in Hyperglycaemic Emergencies, Eli Lilly & Co. Lagos
Natural Health I-III, Review of Parkinson’s Disease Treatment, Walgreens Health Initiatives - HealthPlus
Academy, July 2009
Monitoring and Evaluation Fundamentals, USAID Global Health e-learning centre, Oct 2008
Management of Tuberculosis/HIV co-infection, Imo State Action Committee on HIV/AIDS, May 2008
Family & Community Life Education, Millennium Development Goals (MDGs) Programme, Oct 2007
PROJECTS AND LEADERS HIP
Team Lead, Neutropenia Project, Roche Products, 2012-2013
Facilitator/Coordinator, Nigerian Oncology Pharmacy Project, 2011-2014.
Member, Electoral Committee, Students’ Chemical Society of Nigeria, University of Ibadan, 2000-2001
Secretary, Year-book Committee, Faculty of Pharmacy Graduating Class, 2005-2006
Senior Prefect, Wesley College of Science, Ibadan, 1998-1999
Vice-President, Junior Engineers, Technicians & Scientists’ (JETS) club, Wesley College of Science, 1998-9.
HONORS AND AW ARDS







Recognition Award for contribution to the Oncology franchise, Roche Products, Dec 2012
Best Representative Award, Oncology Franchise, Roche Products, Mar-June, Sept-Nov, 2012
Best Student, Dept. of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, 2006
Dean’s roll of Honor Award, Faculty of Science, University of Ibadan, 2000
Best in Mathematics, Junior Engineers, Technicians & Scientists’ (JETS) club, Wesley College
of Science, 1999.
SKILLS AND COMPETENCIES
Operational competency in Business analytics programs; Qlikview and Salesforce.com.
Statistical Analysis.
VOLUNTEER AND COMMUNITY SERVICE
Run for a cure Africa (Breast Cancer Advocacy Group), Volunteer
2014
Corpers’ Health Team (COHET), a Community Development Group
2007- 2008
Assistant Secretary General and Editor, The Consult Magazine, Annual COHET Publication.
SOCIETIES AND PROFES SIONAL AFFILIATIONS




Member: American Society of Clinical Oncology (ASCO)
Member: International Society for Pharmacoeconomics & Outcomes Research (ISPOR)
Member: Pharmaceutical Society of Nigeria (PSN)
Member: Nigerian Institute of Management (NIM).